NCCN 2012 Congress Webinar Series: Genitourinary Cancers™: Treatment of Advanced Prostate Cancer
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This activity is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Outline patient selection criteria for the proper use of novel agents in advanced prostate cancer
- Describe novel agents approved for advanced prostate cancer
Sandy Srinivas, MD
Stanford Cancer Institute
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician